1541 fundamentals
IMMUNEONCO BIOPHARMACEUTICALS (SHAN earnings per share and revenue
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise